Amend 007 - DISO Adenovirus - Teva Pharmaceuticals USA Inc
Status Expired
Contract number W6369-19A009/001/PH
Solicitation number W6369-19A009/A
Publication date
Contract award date
Last amendment date
Contract value
CAD
0.00
Description
This contract was awarded to:
Teva Pharmaceuticals USA, Inc.
Adenovirus 4 & 7
- Business address
-
400 Interpace PkwyParsippany, New Jersey, 07054-1120US
- Notice type
- Request for Supply Arrangement
- Language(s)
-
English,French
- Selection criteria
- Not applicable
Contract duration
The contract will be for a period of 40 month(s), from 2020/05/20 to 2023/10/06.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.CAD 0.00
Commodity - UNSPSC
- 51000000 - Drugs and Pharmaceutical Products
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Contact information
Contracting organization
- Organization
-
Department of Public Works and Government Services (PSPC)
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Chan, Lina (SPAC/PSPC) (elle-la / she-her)
- Email
- lina.chan@tpsgc-pwgsc.gc.ca
Related notices
Tender notices (1) This award notice has 1 related tender notices. Click to collapse
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| Adenovirus Vaccine | W6369-19A009/A | 2018/08/31 | 2018/09/17 |
Contract history (8) This award notice has 8 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
